Software developer Intelerad Medical Systems said today that it is investing $75 million into research and development as it looks to grow its software solutions portfolio.
The Montreal-based company said that its existing platforms enable radiologists to perform more than 200,000 diagnostic interpretations globally.
Intelerad said that it expects the new investment, alongside its continued creation of solutions, will fuel a two-fold increase in study volume.
“I’ve had the pleasure of using Intelerad technology in my daily work for 17 years, the company truly understands the needs of the medical imaging community. Intelerad solutions are highly versatile, extremely intuitive and constantly evolving to meet the needs of the market. They have a huge impact on efficiency and are critical for streamlining communication between care team members, which enables us to provide the highest quality patient care,” Dr. Giovanni Artho of the McGill University Health Centre said in a prepared statement.
The company said that it has expanded its workforce by 30% over the past three years, and expects to double in size over the next five years as it picks up additional subject matter experts and technologists to enable the quicker development of healthcare-related solutions.
“Medical imaging has undergone a significant transformation over the past 20 years, and Intelerad has been at the forefront of that evolution. We are proud to support customers around the world in providing the highest standard of healthcare services. We will continue to make a difference in healthcare by delivering scalable, enterprise-wide medical imaging solutions for healthcare providers and their patients,” prez & CEO Paul Lepage said in a press release.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!